Advertisement

Surgical Techniques for Multimodality Treatment of Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy and Pleurectomy/Decortication

      Trimodality treatment of malignant pleural mesothelioma with cytoreductive surgery followed by radiation and chemotherapy has resulted in long-term survival for a select group of patients. Knowledge of the similarities and differences between the two operations that have evolved—extrapleural pneumonectomy and pleurectomy/decortication—is prerequisite to understanding the complex issues associated with patient selection, diagnosis, pathologic staging, preoperative assessment, perioperative management, and adjuvant treatment. Both operations are technically complex and should only be performed at experienced high-volume centers.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sugarbaker D.J.
        • Jaklitsch M.T.
        • Bueno R.
        • et al.
        Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.
        J Thorac Cardiovasc Surg. 2004; 128: 138-146
        • McCormack P.M.
        • Nagasaki F.
        • Hilaris B.S.
        • et al.
        Surgical treatment of pleural mesothelioma.
        J Thorac Cardiovasc Surg. 1982; 84: 834-842
        • Patz E.J.
        • Shaffer K.
        • Piwnica-Worms D.
        • et al.
        Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
        AJR Am J Roentgenol. 1992; 159: 961-966
        • Mujoomdar A.A.
        • Sugarbaker D.J.
        Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma.
        Semin Thorac Cardiovasc Surg. 2008; 20: 298-304
        • Byrne J.G.
        • Karavas A.N.
        • Colson Y.L.
        • et al.
        Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy.
        Chest. 2002; 122: 2256-2259
        • Bagshaw S.M.
        • Galbraith P.D.
        • Mitchell L.B.
        • et al.
        Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis.
        Ann Thorac Surg. 2006; 82: 1927-1937
        • Van Mieghem W.
        • Coolen L.
        • Malysse I.
        • et al.
        Amiodarone and the development of ARDS after lung surgery.
        Chest. 1994; 105: 1642-1645
        • Handschin A.E.
        • Lardinois D.
        • Schneiter D.
        • et al.
        Acute amiodarone-induced pulmonary toxicity following lung resection.
        Respiration. 2003; 70: 310-312